Process Reliability Engineer
About the job
- A bachelor's or master's degree in Engineering or equivalent is required.
- A minimum of 5 years of experience in manufacturing, process engineering, quality, or reliability engineering is required.
- Demonstrated experience executing Process Failure Mode and Effects Analysis, developing and enforcing control plans, and applying Statistical Process Control (Cp/Cpk) to sustain process capability is required.
- Proven ability in root cause analysis and structured problem solving is required.
- Strong analytical and data interpretation capability, including the ability to drive systemic and sustainable improvements, is required.
- Effective stakeholder management across cross-functional teams is required.
- A strong focus on process discipline, prevention, and compliance is required.
- A proven track record in building robust, self-sustaining processes is required.
- Proactively eliminate process risks and establish governance frameworks, including Process Failure Mode and Effects Analysis, control plans, and Statistical Process Control, to ensure disciplined process control and sustained capability.
- Establish and sustain robust reaction plans for out-of-control conditions.
- Review and enhance risk-based qualification strategies and test plans to ensure robust and compliant processes.
- Analyze manufacturing data, including nonconformance trends, yield, and defects, and field performance data to detect potential process gaps.
- Translate insights into targeted improvement actions and eliminate recurring risks through systemic root cause resolution, strengthening process consistency and stability.
- Strengthen visibility of issues and process performance through data systems to enable faster detection, decision-making, and response.
- Lead the cross-functional team on field and customer issue feedback, such as defects on arrival, and provide timely updates to stakeholders.
- Oversee overall manufacturing process performance, manage communications or conduct periodic reviews to highlight key opportunities or risks, and drive continuous improvement.
About the company
Agilent Technologies provides eProcurement services that help businesses buy supplies more efficiently. It offers a suite of electronic procurement tools that let clients load their pricing into existing purchasing platforms, access a hosted catalog, and complete transactions digitally without paper. The service connects pricing data to clients’ procurement systems, delivers an online catalog, and supports automated, paperless purchasing workflows. This makes purchasing faster and reduces manual steps. Compared with competitors, Agilent emphasizes automation, quick connectivity between pricing, catalogs, and purchasing platforms, and a reliable, scalable experience backed by its broad product range. The company aims to improve client productivity and lower procurement costs, helping customers buy what they need more easily while keeping prices clear and consistent.
Company Size
10,001+
Company Stage
IPO
Headquarters
Santa Clara, California
Founded
1999
Get referred to Agilent Technologies
See people who can refer or advise you
Simplify's Take
What believers are saying
- Q3 FY2026 revenue hit $1.88 billion, up 8.1%, and guidance rose to $7.51 billion.
- China grew 9% and pharma grew 12%, signaling stronger end markets.
- September 2026 launches, including S540MD and Gen5 AI, expand higher-value digital pathology.
What critics are saying
- Tariff refunds added 110 basis points to Q3 margin, masking underlying profitability.
- FY26 restructuring costs and workforce reductions continue through first-quarter 2027.
- A failed pathology pivot leaves Agilent overexposed to slower instrument cycles and commoditization.
What makes Agilent Technologies unique
- Agilent combines instruments, software, and consumables across pathology, imaging, and analytics.
- The June 2026 Biocare Medical acquisition deepens its pathology menu and clinical reach.
- June 2026 OpenAI and BCG collaboration pushes AI into products, operations, and workflows.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Remote Work Options
Performance Bonus
Stock Options
Growth & Insights and Company News
6 month growth
3%1 year growth
0%2 year growth
0%Agilent Technologies Inc. agreed to buy Proscia, a digital pathology software provider, in an all-cash deal valued at $240 million at closing. Proscia's founders could earn up to $30 million more if it meets future performance milestones. Proscia's software connects slide scanners, laboratory systems, and AI tools in one platform. It serves more than 4,000 laboratories, hospitals, and clinics, and 16 of the top 20 pharmaceutical companies. Its trailing twelve-month revenue exceeds $18 million. The companies have worked together since a September 2022 distribution agreement. Agilent expects Proscia's recurring-revenue software to add a high-growth, high-margin business to its pathology portfolio. The deal is subject to customary closing conditions and is expected to close early in Agilent's fiscal year 2027.
Agilent Technologies has launched the BioTek Gen5 AI cell identification module, a new image analysis software add-on for its BioTek automated imaging systems. The module uses AI-based cell identification and segmentation, eliminating the need for conventional threshold setting or parameter tuning. The technology addresses challenges researchers face with threshold-based segmentation, which requires establishing and optimising analysis parameters for individual experiments. This process can introduce user-dependent variation and create difficulties in high-throughput imaging workflows. The module supports label-free and fluorescence applications, as well as live-cell and kinetic assays commonly used in life science and pharmaceutical research. It integrates with Gen5 software, allowing researchers using compatible BioTek Cytation and Lionheart automated imagers to apply AI-based segmentation within existing workflows. Agilent generated revenue of $6.95 billion in fiscal year 2025 and employs approximately 18,000 people worldwide.
Agilent Technologies launched the S540MD slide scanner in the United States on 4 September. The FDA-cleared device can hold up to 540 glass slides at once and targets pathology labs managing high sample volumes and preparing for AI-assisted workflows. The scanner automates routine tasks and integrates with existing laboratory setups. It reached select European markets in January and is now available in Germany, the UK, France, and other European countries alongside the US. Agilent reported revenue of $1.88 billion for the quarter ended 31 July, up 8.1% year-on-year. Non-GAAP earnings per share rose 18%. Management raised full-year non-GAAP earnings guidance to $6.18 to $6.21 per share. The S540MD is a rebadged Hamamatsu NanoZoomer S540MD. Agilent has not disclosed pricing or revenue targets for the product.
Agilent Technologies announced that Koh Boon Hwee retired from its board of directors on 4 September 2026, after more than 20 years of service. Koh joined the board in 2003 and served as independent chair from 2017 until his retirement. Dow R. Wilson, a board member since 2018, was elected as the new chair. Wilson currently chairs the Audit and Finance Committee. The company also appointed Glenn Boehnlein to its board, effective 4 September 2026. Boehnlein spent 22 years at Stryker Corporation, serving as vice president and chief financial officer from 2016 until his retirement in 2025. He currently serves on the boards of Inogen and Sutter Health.
Agilent Technologies has launched the Cary 635 FTIR spectrometer, described as the smallest Fourier transform infrared analyser in its class. The compact instrument combines high-performance analysis with user-friendly operation, requiring minimal technical training. The spectrometer features solid ZnSe optical components for enhanced moisture resistance and improved sensitivity for analysing lower-concentration samples. Its modular architecture supports analysis of solids, liquids, powders, and gases, whilst permanently aligned optics enable rapid interchange of sampling modules. The device includes MicroLab software with step-by-step workflows and colour-coded results, allowing novice users to be trained quickly. Agilent generated $6.95 billion in revenue during fiscal year 2025 and employs approximately 18,000 people worldwide.